Tuesday, September 27, 2016 10:18:10 AM
http://translate.google.com/translate?u=http%3A%2F%2Fwww.e-ande.com%2Ftechnology.php%3Fid%3D2&hl=en&langpair=auto|zh-TW&tbb=1&ie=UTF-8
Amorphous Alloy
Materials, information and energy are the three pillars of modern technology, in which the material is the most basic. Amorphous alloy material because of its high strength, good corrosion resistance, toughness, excellent electromagnetic properties, high resistivity, good wear resistance, thermal expansion coefficient of small outstanding physical and chemical properties show strong development potential, be regarded as New Materials for the 21st Century.
Amorphous alloy material is one of the super-materials which will lead the future high-tech competition. It has important application prospects in medical, consumer electronics, aerospace, biomedicine and precision machinery. It may gradually replace the existing materials, The company as the industry earlier in the liquid metal research and development of one of the enterprises, mastered the liquid metal products in materials, processes, equipment and other aspects of the core technology.
The company has made a series of achievements in terms of the amorphous, patents, the company has three invention patents authorized amorphous aspect, application 10 invention patents, utility model patents authorized five. Formation and technological achievements "Zr-Cu-Ni-Ag -Y amorphous alloy precision die casting technology and application of" state-level appraisal, the leading domestic and international advanced level.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM